Daxor Will Showcase Diagnostic Tech in Phoenix
Daxor Corporation will exhibit its Blood Volume Analyzer at the Heart Failure Society of America meeting in October.
Updated on Oct. 1, 2026 in Heart Disease
Live Poll
Do you believe new medical diagnostic technologies generally improve patient outcomes in hospital settings?
Daxor Corporation will present its FDA-cleared Blood Volume Analyzer at the Heart Failure Society of America Annual Scientific Meeting in Phoenix, Arizona, from October 9-12, 2026. The company intends to highlight its diagnostic platform for attending clinicians and hospital administrators.
Why it matters
The exhibition serves as a platform for Daxor to showcase clinical evidence and functional upgrades to a professional medical audience. The event aims to foster widespread clinical adoption of the diagnostic technology in hospital settings.
The next-generation analyzer offers a 3x speed increase compared to the BVA-100 platform while maintaining greater than 95% measurement accuracy. The system requires 50% less blood volume for testing.
The players
Daxor Corporation
This is a medical instrumentation company that develops blood volume measurement technology for clinical use.
Heart Failure Society of America
This professional organization is dedicated to advancing research and education in the field of heart failure.
The details
Independent clinical researchers are scheduled to present two ePosters at the meeting on October 10, 2026. Daxor Corporation will host attendees at Booth #803 to provide demonstrations of the hardware throughout the conference.
Timeline
October 9-12, 2026: The HFSA Annual Scientific Meeting takes place.
October 10, 2026: Clinical researchers will present two ePosters.
Health Landscape
This exhibition at the Heart Failure Society of America Annual Scientific Meeting follows the pattern set by other medical technology firms utilizing the conference to introduce upgraded diagnostic devices to the clinical community. The move reflects a broader trend of companies seeking to validate proprietary systems through independent peer-reviewed presentations.
The adoption of faster, less invasive diagnostic platforms can improve the efficiency of clinical workflows in hospitals. These advancements may lead to more accurate blood volume management for patients undergoing cardiac treatment.
The takeaway
Advancements in diagnostic instrumentation focus on balancing technical precision with minimal invasiveness for the patient. Improved device efficiency aims to support hospital staff in delivering faster, more reliable medical assessments.
What happens next
Independent clinical investigators will present their ePoster findings on October 10, 2026, at the conference.
Further reading
Learn more about the latest innovations in cardiac care on the Heart Disease section.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you believe new medical diagnostic technologies generally improve patient outcomes in hospital settings?
